Showing results (1801-1810 of 1,866) with videos related to

Sort By:
Pageof 187
Leukemia|March 29, 2022
Autologous or allogeneic hematopoietic cell transplantation for relapsed or refractory PTCL-NOS or AITLKazuaki Kameda, Shinichi Kako, Sung-Won Kim, et al.
Journal of Medicinal Chemistry|January 18, 2019
Design, Synthesis, and Biological Evaluation of Retinoic Acid-Related Orphan Receptor γt (RORγt) Agonist Structure-Based Functionality Switching Approach from In House RORγt Inverse Agonist to RORγt AgonistTomoya Yukawa, Yoshi Nara, Mitsunori Kono, et al.
Hematology (Amsterdam, Netherlands)|April 29, 2025
Insights into very elderly multiple myeloma treatment from Kansai Myeloma ForumYusuke Okayama, Teruhito Takakuwa, Yuji Shimura, et al.
Bioorganic & Medicinal Chemistry|December 21, 2017
Discovery of orally efficacious RORγt inverse agonists. Part 2: Design, synthesis, and biological evaluation of novel tetrahydroisoquinoline derivativesMitsunori Kono, Tsuneo Oda, Michiko Tawada, et al.
Ejhaem|July 18, 2022
Significance of maintenance therapy after HDT/ASCT in symptomatic multiple myeloma: A multicenter retrospective analysis in Kansai Myeloma ForumAya Nakaya, Hirohiko Shibayama, Eiji Nakatani, et al.
Nature Communications|October 3, 2025
SFPQ-TFE3 reciprocally regulates mTORC1 and induces lineage plasticity in a mouse model of renal tumorigenesisKaushal Asrani, Adrianna Amaral, Juhyung Woo, et al.
Nature Communications|February 11, 2021
Plasma cells are enriched in localized prostate cancer in Black men and are associated with improved outcomesAdam B Weiner, Thiago Vidotto, Yang Liu, et al.
Science Advances|May 28, 2019
Molecular mechanism and potential target indication of TAK-931, a novel CDC7-selective inhibitorKenichi Iwai, Tadahiro Nambu, Ryo Dairiki, et al.
Blood Advances|December 21, 2021
Establishment of a predictive model for GVHD-free, relapse-free survival after allogeneic HSCT using ensemble learningMakoto Iwasaki, Junya Kanda, Yasuyuki Arai, et al.
Annals of Hematology|April 14, 2026
Donor selection for patients with HLA-homozygous haplotypes in allogeneic hematopoietic stem cell transplantationNoriyoshi Yoshinaga, Makoto Iwasaki, Koji Kato, et al.
Pageof 187